Argan is trading at $274.40, up 5.05%, recovering part of its sharp two-session decline; no clear company-specific announcement explaining the November 6 pre-market gain surfaced in available coverage.

  • Investors had been weighing strong fiscal second-quarter results against a shrinking backlog and weaker industrial margins, concerns highlighted in recent reporting.
  • Those concerns do not establish the cause of the rebound, and broader market signals are mixed.